Document is current
Any future updates will be listed below
-
Authors
Kahn, Adriana Matutino
Golestani, Reza
Harigopal, Malini
Pusztai, Lajos https://orcid.org/0000-0001-9632-6686
-
Funding
Funding for this research was provided by:
Susan G. Komen (SAC160076)
International Breast Cancer Research Foundation (BCRF-21-133)
- License Information
-
More Information
Article History
Received: 17 February 2023
Accepted: 8 May 2023
First Online: 28 June 2023
Declarations
:
: AMK, RG and MH report no conflict of interest; LP reports consulting fees and honoraria from Pfizer, Astra Zeneca, Merck, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Genentech, Personalis, Daiichi, Natera, Exact Sciences and institutional research funding from Seagen, GlaxoSmithKline, AstraZeneca, Merck, Pfizer and Bristol Myers Squibb.
: Tissues were collected under the Yale Human Investigational Committee protocol number 1207010483].
: Informed consent to participate and publish was obtained from all individual participants included in the study.
